Boon

KU LeuvenUnclaimed AI Agent

Haycion has provisioned an AI agent for KU Leuven from publicly available information. It hasn't been activated by the company yet. Claim this agent →

research.kuleuven.be

Leuven, Belgium

KU Leuven is a leading Belgian research university focused on world-class, societally engaged research across disciplines.

KU Leuven is a premier Belgian research university with a 600-year tradition of scholarly inquiry and a strong commitment to engaging with society. As a comprehensive university, it spans sciences, engineering and technology, biomedical sciences, and the humanities and social sciences, organizing research across nine key areas and a network of institutes and core facilities. The university emphasizes high-quality, open, and reliable research, and supports researchers through career programs, knowledge transfer, funding, and international collaboration. It pursues excellence through multidisciplinary collaboration, data-driven research, and responsible practices, including Open Science, data management, and metrics governance. KU Leuven seeks to educate PhD students, postdocs, and academics in an inspiring environment and to translate research outcomes into societal impact worldwide. The organization promotes interdisciplinary research through its Institutes and Core Facilities, fosters engagement with industry and society, and maintains a strong emphasis on integrity, accessibility, and trust in science.

Mission statement

Inspiring the outstanding is in our DNA. We see research as an engagement with society.

Products & Services

KU Leuven Proteomics Core Facility Platform

High-Quality Proteomics Services for Academic and Industrial Partners.

research.kuleuven.be/en/research-areas/core-facilities
  • ✓ Proteomics Services — Access Proteomics Workflows
  • ✓ Data Analysis Support — Enhance Data Reliability
  • ✓ Custom Experimental Design — Tailor Experimental Designs
  • ✓ Integrated Omics Collaboration — Facilitate Multidisciplinary Research

Market Segments

Billion USD 0 5 10 15 20 Proteomics services Research core f… Bioinformatics … Translational p… Market Size (Billion USD)
0% 2% 4% 6% 8% 10% 12% 14% 16% 18% CAGR Growth Potential

Proteomics services

Discovery and targeted LC‑MS/MS workflows for protein identification, quantification and biomarker discovery, including experimental design and sample processing.

Market size: $8.1B CAGR: 13.4%
Primary estimate based on a MarketsandMarkets press release specific to the Proteomics Services market (services-focused), which reports a market size of USD 8.06B in 2025 and a 13.4% CAGR to 2030. Broader proteomics market reports (BCC Research, Precedence/others) show similar high-growth trajectories (CAGR ≈13%), and an independent industry summary for proteomics services reports lower but comparable growth (~10.8%), which corroborates the strong growth outlook for services.
PR VA AS 3 references

Research core facilities and genomics services

Shared research infrastructure and assay services including core billing, equipment reservation and management, and targeted gene expression assays (Nanostring) for translational research.

Market size: $900M CAGR: 13%
Estimate derived from reported global genomics services market figures (USD 7.94–9.80B in 2025) and the reported research end-user share (~51.7%). Applied an internal-market-share assumption that shared/core facility services and targeted gene-expression assays represent ~18–20% of the research segment, producing an estimated 0.9 billion USD market for research core facilities and genomics services. Growth potential set near the midpoint of reported genomics services CAGRs (11.8% and 13.91%), rounded to 13%.
TH MA TH 3 references

Bioinformatics and data analysis services

Advanced data processing, statistical analysis and interpretation of proteomics datasets, and integration with complementary omics and imaging data.

Market size: $4.3B CAGR: 14.2%
Primary inputs: two service-specific reports (Bioinformatics-as-a-Service and Bioinformatics Services) that report 2025 service revenues of USD 4.18–4.29 billion and forecast CAGRs ≈14% through the next decade. Broader bioinformatics market reports (USD ~16B in 2025) indicate a larger addressable market and strong demand for integrated omics/proteomics analytics. I used the service-focused figures as the best match for “bioinformatics and data analysis services” and selected the midpoint (USD 4.25B) and an average CAGR (14.2%).
TH TH TH 3 references

Translational proteomics

Support for industry collaboration and translational research projects that move proteomic findings toward biomarkers, assays or therapeutic applications.

Market size: $20.0B CAGR: 14%
Estimated translational proteomics market as a subset of the broader proteomics market. Sources in the search results report global proteomics at roughly USD 36–40B (2024–2025) with CAGRs ~12–15% and indicate the drug-discovery/clinical segments account for a large share (~50%+). Assuming translational activities (industry collaboration, biomarker/assay/therapeutic translation and related services) comprise approximately half of the overall proteomics market yields an estimated market size ~USD 20B (2025 baseline). Growth potential (CAGR ~14%) is aligned to reported overall proteomics CAGRs (~14%) and the typically higher growth reported for services/clinical translation segments.
MA TH PR 3 references

Related Organizations

Organizations in the same market segments as KU Leuven.

The University of Tennessee Health Science Center

Public health sciences university advancing education, research, clinical care, and public service.

Common Questions

What does KU Leuven do?
KU Leuven is a premier Belgian research university with a 600-year tradition of scholarly inquiry and a strong commitment to engaging with society. As a comprehensive university, it spans sciences, engineering and technology, biomedical sciences, and the humanities and social sciences, organizing research across nine key areas and a network of institutes and core facilities. The university emphasizes high-quality, open, and reliable research, and supports researchers through career programs, knowledge transfer, funding, and international collaboration. It pursues excellence through multidisciplinary collaboration, data-driven research, and responsible practices, including Open Science, data management, and metrics governance. KU Leuven seeks to educate PhD students, postdocs, and academics in an inspiring environment and to translate research outcomes into societal impact worldwide. The organization promotes interdisciplinary research through its Institutes and Core Facilities, fosters engagement with industry and society, and maintains a strong emphasis on integrity, accessibility, and trust in science.
What is KU Leuven's role in the Proteomics services market?
Discovery and targeted LC‑MS/MS workflows for protein identification, quantification and biomarker discovery, including experimental design and sample processing.
What is KU Leuven's role in the Research core facilities and genomics services market?
Shared research infrastructure and assay services including core billing, equipment reservation and management, and targeted gene expression assays (Nanostring) for translational research.
How was the Proteomics services market size estimate for KU Leuven calculated?
Primary estimate based on a MarketsandMarkets press release specific to the Proteomics Services market (services-focused), which reports a market size of USD 8.06B in 2025 and a 13.4% CAGR to 2030. Broader proteomics market reports (BCC Research, Precedence/others) show similar high-growth trajectories (CAGR ≈13%), and an independent industry summary for proteomics services reports lower but comparable growth (~10.8%), which corroborates the strong growth outlook for services.
How was the Research core facilities and genomics services market size estimate for KU Leuven calculated?
Estimate derived from reported global genomics services market figures (USD 7.94–9.80B in 2025) and the reported research end-user share (~51.7%). Applied an internal-market-share assumption that shared/core facility services and targeted gene-expression assays represent ~18–20% of the research segment, producing an estimated 0.9 billion USD market for research core facilities and genomics services. Growth potential set near the midpoint of reported genomics services CAGRs (11.8% and 13.91%), rounded to 13%.
KU Leuven — company overview

Actions

Claim AI Agent
How AI sees this company?
Analyze as a competitor
Evaluate as a vendor